Company / FCF Margin
Tvardi Therapeutics, Inc. FCF Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-188.2%
FY2024
5-year range
-549.4% / -4.3%
FY2020-FY2024
Trend
+27.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -55927.9% in FY2018 to 23.6% in FY2015.
Based on SEC 10-K filings.
-188.2% in FY2024 with a 5-year CAGR of +5836.5%.
Declined from -4.3% to -188.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +361.2pp
- 5-Year Change
- +5836.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin increased 27.9% year-over-year.
- Peak fcf margin was recorded in FY2015.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -188.2% | +27.9% |
| FY2023 | -261.1% | -5944.0% |
| FY2022 | -4.3% | +99.2% |
| FY2021 | -549.4% | -230.7% |
| FY2020 | -166.1% | +97.2% |
| FY2019 | -6024.7% | +89.2% |
| FY2018 | -55927.9% | -9793.7% |
| FY2017 | -565.3% | -1.6% |
| FY2016 | -556.6% | -2458.6% |
| FY2015 | 23.6% | +104.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026